Good morning :)
Place Order
Add to Watchlist

Balaji Amines Ltd

BALAMINES

Balaji Amines Ltd

BALAMINES
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹6,556 cr, stock is ranked 711
Moderate RiskStock is 2.59x as volatile as Nifty
2,016.000.35% (+7.10)
2,016.000.35% (+7.10)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹6,556 cr, stock is ranked 711
Moderate RiskStock is 2.59x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹6,556 cr, stock is ranked 711
Moderate RiskStock is 2.59x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
32.513.460.54%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
31.173.551.31%

Forecast & Ratings

Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Balaji Amines Limited is a company, which is engaged in the manufacturing of Aliphatic Amines, their derivatives and specialty chemicals. The Company is running a five star hotel, Balaji Sarovar Premiere.

Investor Presentation

View older 

Nov 19, 2024

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 12.02%, vs industry avg of 6.15%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 1.71% to 1.97%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 11.75%, vs industry avg of -1.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue645.92679.74873.36947.28940.781,317.532,337.602,370.651,671.151,563.45
Raw Materialssubtract330.53347.33460.97541.01497.97615.801,276.411,261.20916.251,230.24
Power & Fuel Costsubtract62.4257.9476.5284.7095.03125.02209.93237.59169.89
Employee Costsubtract21.6324.4726.8929.4734.0733.5696.6485.2182.27
Selling & Administrative Expensessubtract62.5068.9787.5992.5190.89124.20134.52131.58117.33
Operating & Other expensessubtract39.3422.6927.231.9537.0639.64-17.2830.7032.04
Depreciation/Amortizationsubtract19.3819.7119.2919.5531.6234.4142.0045.5745.3746.75
Interest & Other Itemssubtract22.1512.949.0413.0323.0318.2917.1011.976.444.90
Taxes & Other Itemssubtract30.3543.3452.6647.5326.3088.40209.87241.2996.7079.89
EPS17.7825.4234.9336.2732.3573.52113.70100.4763.2362.24
DPS2.002.202.602.803.204.006.0010.0011.0011.00
Payout ratio0.110.090.070.080.100.050.050.100.170.18

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual report

PDF

Investor Presentation

May 12PDF
Feb 3PDF
Oct 28PDF
Aug 4PDF
FY 2023

Annual report

PDF

Investor Presentation

May 22PDF
Feb 7PDF
Oct 28PDF
Aug 13PDF
FY 2024

Annual report

PDF

Investor Presentation

Sep 2PDF
FY 2025

Annual Report Pending

Investor Presentation

Nov 19PDF
 

Peers & Comparison

Comparing 3 stocks from 
MaterialsSpecialty Chemicals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Balaji Amines Ltd32.003.460.54%
Gujarat Fluorochemicals Ltd112.508.240.07%
Vinati Organics Ltd60.027.870.37%
Navin Fluorine International Ltd66.877.590.41%

Price Comparison

Compare BALAMINES with any stock or ETF
Compare BALAMINES with any stock or ETF
BALAMINES
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding53.70%0.14%1.65%5.27%39.24%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep4.55%4.52%4.57%4.92%5.05%5.27%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Balaji Amines Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Nippon India Nifty Smallcap 250 Index Fund - Growth - Direct Plan

Growth
0.0346%0.12%-0.01%142/294 (0)
DSP Nifty Smallcap250 Quality 50 Index Fund - Growth - Direct Plan

Growth
0.0305%1.12%-0.04%45/52 (-1)
SBI Nifty Smallcap 250 Index Fund - Direct Plan - Growth

Growth
0.0221%0.12%-0.01%105/294 (-1)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

Increasing Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

BALAMINES has increased dividends consistently over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.54%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹5.44 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateJul 4, 2024

Final
Final | Div/Share: ₹11.00

Dividend/Share

₹11.00

Ex DateEx Date

Jul 4, 2024

Cash Dividend

Ex DateEx DateJul 3, 2023

Final
Final | Div/Share: ₹10.00

Dividend/Share

₹10.00

Ex DateEx Date

Jul 3, 2023

Cash Dividend

Ex DateEx DateJun 21, 2022

Final
Final | Div/Share: ₹6.00

Dividend/Share

₹6.00

Ex DateEx Date

Jun 21, 2022

Cash Dividend

Ex DateEx DateJul 29, 2021

Final
Final | Div/Share: ₹4.00

Dividend/Share

₹4.00

Ex DateEx Date

Jul 29, 2021

Cash Dividend

Ex DateEx DateJul 30, 2020

Final
Final | Div/Share: ₹0.60

Dividend/Share

₹0.60

Ex DateEx Date

Jul 30, 2020

News & Opinions
Spotlight
Balaji Amines Q2 PAT rises 18% YoY to Rs 41 crore

Revenue from operations declined 8.85% year on year (YoY) to Rs 346.88 crore in the quarter ended 30 September 2024. Profit before tax stood at Rs 56.81 crore in September 2024 quarter, registering a growth of 18.33% on YoY basis. Sequentially, the company's net profit and revenue from operations in second quarter of FY25 declined 5.34% and 9.84%, respectively. EBITDA during the quarter stood at Rs 70 crore, down 5.41% as compared to Rs 74 crore in Q1 of FY25. EBITDA margin for Q2FY25 improved to 20% in Q2 FY25 as against 19% reported in the same period a year ago. Total expenses declined 11.8% YoY to Rs 299.26 crore during the quarter. Cost of raw material consumed stood at Rs 221.88 crore (up 16% YoY) while other expenses were at Rs 78.92 crore (down 7.31% YoY) in Q2 FY25. The company's revenue from amines amines derivatives volumes stood at 8,685 MT and specialty chemicals volumes stood at 10,046 MT. Looking ahead, Balaji Amines is proposing to set up a plant for manufacture of N-(N-Butyl) Thiophosphoric Triamide (NBPT) with a capacity of 2500 TPA which will be taken up next Financial Year. Additionally, the company aims to expand its ACN production capacity by setting up a new plant with a 60 MT/day capacity at Unit-III in MIDC, Chincholi. The discussion for transfer of the latest technology (reducing the cost of production) is under final stage and the company may sign the agreement by the end of November 2024. New equipment as per the latest technology will be integrated with the existing ACN plant at Unit-III. In a separate development, Balaji Speciality Chemicals, a subsidiary of Balaji Amines, has planned a major expansion with an investment of approximately Rs 750 c rore. This project will focus on a range of products, including Hydrogen Cyanide (HCN), Sodium Cyanide (NaCN) in both 30% solution and 100% solid forms, EDTA, EDTA-2Na, Benzyl Cyanide (BnCN), Phenylacetic Acid (PAA), and Tri Ethyl Ortho Formate (TEOF)/Tri Methyl Ortho Formate (TMOF). D. Ram Reddy, managing director, Balaji Amines, said, 'In the Q2 quarter, we reported a revenue of Rs 356 crore, achieving an EBITDA margin of 20%. This marks a 110-basis-point improvement over last quarter, reflecting our focus on higher margin products amid a challenging industry environment. While the broader market experienced pressure in Q2, both the API and agrochemical looks promising over a long term, and we are well-positioned to seize these future opportunities. With our expanded capacities and a sharpened focus on operational efficiency, we are confident in our ability to drive sustainable growth in the coming quarters. Our recent developments demonstrate significant progress in expanding our production capacity. With the successful commencement of Methylamines production at Unit-IV, our total annual installed capacity has increased from 48,000 MT to 88,000 MT across all three units. Additionally, Unit-I and Unit-III have achieved BIS Certification for 'Morpholine,' strengthening our quality standards and making us the only BIS-certified Morpholine manufacturer in India. Projects in Electronic Grade DMC, Propylene Glycol Pharma Grade, and Dimethyl Ether are also advancing well, reflecting our commitment to operational excellence. As we look forward, our strong foundation in core capabilities positions us well to navigate industry dynamics and capture growth opportunities.' Balaji Amines is a leading manufacturer of aliphatic amines in India. Broadly, the company is specialized in manufacturing methyl amines, ethyl amines, derivatives of specialty chemicals and natural product and its business is broadly classified into three segments - amines, specialty chemicals and derivatives. Shares of Balaji Amines declined 1.92% to Rs 1,996.15 on the BSE. Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Earnings
Balaji Amines consolidated net profit rises 18.06% in the September 2024 quarter

Net profit of Balaji Amines rose 18.06% to Rs 40.98 crore in the quarter ended September 2024 as against Rs 34.71 crore during the previous quarter ended September 2023. Sales declined 8.85% to Rs 346.88 crore in the quarter ended September 2024 as against Rs 380.54 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales346.88380.54 -9 OPM %17.4914.14 - PBDT68.8158.79 17 PBT56.8148.01 18 NP40.9834.71 18 Powered by Capital Market - Live

4 weeks agoCapital Market - Live
Corporate
Balaji Amines to declare Quarterly Result

Balaji Amines will hold a meeting of the Board of Directors of the Company on 14 November 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Spotlight
Balaji Amines drops as Q1 PAT slides 18% YoY to Rs 43 cr

Revenue from operations was at Rs 384.75 crore in Q1 FY25, down 17.02% from Rs 463.67 crore recorded in the corresponding quarter previous year. Profit before tax slipped 31.85% year on year to Rs 61.58 crore in the quarter ended 30 June 2024. EBITDA for Q1 FY25 stood at Rs 74 crore, down 28.85% as compared to Rs 104 crore in Q1 FY24. EBITDA margin for Q1FY25 reduced to 19% in Q1 FY25 as against 22% reported in the same period a year ago. Total expense declined 12.57% YoY to Rs 331.28 crore during the quarter. Cost of raw material consumed stood at Rs 193.16 crore (down 31.04% YoY) while employee benefits expenses were at Rs 19.18 crore (up 7.39% YoY) in Q1 FY25. The company's revenue from amines amines derivatives volumes stood at 8,299 MT and specialty chemicals volumes stood at 12,371 MT. On standalone basis, the company's net profit jumped 17.55% to Rs 40.52 crore in Q1 FY25 as against Rs 34.47 crore posted in Q1 FY24. Revenue from operations was at Rs 332.84 crore in Q1FY25, down 1.30% YoY. D. Ram Reddy, Managing Director, Balaji Amines, said, 'During the first quarter of FY25, we achieved a 5% year-on-year increase in volume, however, our top line has been impacted by decrease in realisation led by decrease in Raw material pricing. We are actively managing these challenges and are confident in our ability to navigate through them while maintaining our profitability. The Pharma market is showing encouraging signs of improvement, positioning us well for future growth. Although the Agro Chem market has been slow this quarter, we anticipate improvements in the upcoming quarters as market conditions stabilize. Our capital expenditure projects are progressing as planned. The commissioning of our methylamine plant is on schedule for Q3, and the Dimethyl ether project is expected to be completed by the end of this financial year. These projects are advancing as per the scheduled timelines and are set to significantly enhance our portfolio. Looking ahead, we maintain a positive outlook for long-term opportunities, anticipating growth and increased prospects in the fiscal year 2024-25. We remain dedicated to delivering value to our shareholders and stakeholders through strategic investments and a continued focus on operational excellence.' Balaji Amines is a leading manufacturer of aliphatic amines in India. Broadly, the company is specialized in manufacturing methyl amines, ethyl amines, derivatives of specialty chemicals and natural product and its business is broadly classified into three segments - amines, specialty chemicals and derivatives. Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Balaji Amines consolidated net profit declines 17.90% in the June 2024 quarter

Net profit of Balaji Amines declined 17.90% to Rs 43.29 crore in the quarter ended June 2024 as against Rs 52.73 crore during the previous quarter ended June 2023. Sales declined 17.02% to Rs 384.75 crore in the quarter ended June 2024 as against Rs 463.67 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales384.75463.67 -17 OPM %17.1821.14 - PBDT73.23101.87 -28 PBT61.5890.37 -32 NP43.2952.73 -18 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Balaji Amines to announce Quarterly Result

Balaji Amines will hold a meeting of the Board of Directors of the Company on 7 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live

Balaji Amines gains 3% after subsidiary gets mega project status

11 months agoMoneycontrol

Balaji Amines Q2 Results Review - Significant Decline In Revenue Due To Drop In Price Realisation: KRChoksey

1 year agoBloomberg Quint

Balaji Amines Delays Q1 Results Due To Unavailability Of Management

1 year agoBloomberg Quint

Investors dump Balaji Amines after delay in Q1 results; stock falls

1 year agoMoneycontrol